Search

Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings provide a novel framework for thinking about metastasis and how to treat it.

… Monday, January 13, 2020 Bottom Line:  Scientists at the Sloan Kettering Institute have discovered that the ability of cancers to metastasize to other organs is dependent upon their ability to co-opt natural wound-healing pathways. In a literal sense, metastasis is wound healing gone wrong. These findings

Jae Park, MD, a hematologic oncologist and assistant attending physician at MSK, will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American Association for Cancer Research (AACR) Annual Meeting. This research has been selected to be featured in the meeting’s press program.

… Monday, April 3, 2017 Jae Park, MD , a hematologic oncologist and assistant attending physician at Memorial Sloan Kettering Cancer Center (MSK), will present findings about the durability of CAR T cell therapy response in patients with relapsed B-cell acute lymphoblastic leukemia (B-ALL) at the American

MSK Kids researchers publish report of screening and testing for COVID-19 in pediatric cancer patients in New York City.

… Wednesday, May 13, 2020 Researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) found that children with cancer are not at a higher risk of being affected by COVID-19. This new research led by Andrew Kung, MD, PhD, Chair of MSK Kids and his colleagues was published today in JAMA Oncology

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.

… Wednesday, June 16, 2021 The majority of cancers are caused by random genetic changes and environmental exposures — things like sunlight, tobacco smoke, and the human papillomavirus (HPV). But Memorial Sloan Kettering researchers have found that, at least among people with metastatic or recurrent disease

Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Here are some of the most important developments.

… Wednesday, December 14, 2022 Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in many types of cancer treatment for patients in 2022. Clinical trials reported results of cutting-edge treatments, including new types of immunotherapy , radiation therapy , and experimental targeted

Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson, MD, President and CEO of MSK. MSK’s Carol Brown, MD, Ross Levine, MD, and Robert Sidlow, MD, were also active participants in the discussion. For more information about the event or to request an interview with a MSK roundtable participant, please e-mail [email protected].

… Thursday, May 26, 2016 Vice President Joseph Biden visited Memorial Sloan Kettering Cancer Center (MSK) for a roundtable discussion with MSK experts and members of the cancer community. The candid conversation, inspired by the “moonshot” initiative announced by President Obama, was led by Craig Thompson

For many patients, time is of the essence. At MSK, patients have access to potentially lifesaving therapies long before they are available at community hospitals. Learn how MSK’s Cancer Health Equity Research Program (CHERP) partners with a network of public hospitals in New York City to recruit underserved patients for clinical trials at MSK and give them access to world-class care.

… Tuesday, December 6, 2022 Berta Pesantez knew the outlook wasn’t good. She had stage 4 cancer of the bile duct , and the chemotherapy she was receiving at her local hospital wasn’t working. Out of options, the doctor transferred Berta to the New York’s Queens Cancer Center (QCC), in Jamaica. Berta’s

Select patients with papillary thyroid carcinoma with clinically involved lateral neck nodes may not require prophylactic central compartment neck dissection, enhancing quality of life.

… Monday, August 17, 2020 Select patients with papillary thyroid carcinoma with clinically involved lateral neck nodes (cN1b disease) may not require prophylactic central compartment neck dissection (PCND), according to our retrospective study published recently in the Annals of Surgical Oncology .  (1

Viviane Tabar, MD, has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for Neurosurgical Oncology and the Vice Chair for Neurosurgical Research and Education.

… Wednesday, December 6, 2017 Viviane Tabar, MD , has been named the new Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center (MSK). Dr. Tabar has been a vital faculty member at MSK for more than 15 years and is currently the Theresa C. Feng Chair for Neurosurgical Oncology

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Friday, October 15, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Luis Alberto Diaz, Jr. Appointed to the National Cancer Advisory Board by President Biden Luis Alberto Diaz, Jr. Luis Alberto Diaz, Jr., MD , Head of the Division of Solid Tumor Oncology